|
|
Volumn 344, Issue , 2012, Pages
|
|
Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PIPERAZINE DERIVATIVE;
PURINE DERIVATIVE;
SILDENAFIL;
SULFONE;
VASODILATOR AGENT;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CHRONIC DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
EYE;
EYE DISEASE;
FEMALE;
FOLLOW UP;
HUMAN;
INCIDENCE;
INTRAOCULAR PRESSURE;
LUNG WEDGE PRESSURE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PHASE 3 CLINICAL TRIAL;
PULMONARY HYPERTENSION;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RETROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
VISUAL ACUITY;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
EYE;
EYE DISEASES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPERTENSION, PULMONARY;
INCIDENCE;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
PIPERAZINES;
PULMONARY WEDGE PRESSURE;
PURINES;
QUESTIONNAIRES;
RETROSPECTIVE STUDIES;
SULFONES;
TIME FACTORS;
TREATMENT OUTCOME;
VASODILATOR AGENTS;
VISUAL ACUITY;
MLCS;
MLOWN;
|
|
EID: 84859779899
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.e554 Document Type: Article |
|
Times cited : (43)
|
|
References (0)
|
